Over the counter on NSE Rs. A total traded volume of 3055 shares so far with a value of 1.55 Crores. It traded at a price-to-earnings multiple of 80.71 and a price-to-book ratio of 6.71.
A high price-to-earnings ratio indicates that investors are willing to pay a high price for the earnings per rupee provided by the stock due to good future growth expectations.
Price-to-book value represents the underlying value of a company and the price investors are willing to pay even if there is no growth in the business.
The scrip gained 41.64 per cent during the past one year, while the 30-share index rose 25.4 per cent during the same period.
Divi’s Laboratories Ltd. A pharma – related to the Indian industry.
Promoter/FII holding
Promoters held 51.9 per cent stake in the company as on 30-Jun-2024, while FIIs and domestic institutional investors owned 16.16 per cent and 13.1 per cent respectively.
Chief Financial Officer
For the quarter ended 30-Jun-2024, the company posted Rs. 2197.0 crores, compared to the previous quarter’s Rs. 2382.0 crore as compared to 7.77 percent and year-ago quarter Rs. 1859.0 crore was down by 18.18 percent.
The profit in the latest quarter was Rs. 430.0 crore, which is 20.79 percent higher than the same quarter a year ago.
(You can now subscribe to our ETMarkets WhatsApp channel)
